Physician profile
John J Wilson
NPI 1902855455
$5,460.28
in general payments reported to CMS, 2019-2025
48 companies · $1,211 in 2025
The $1,211 reported for 2025 was more than what 85% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.63 · 2021: $217 · 2022: $1,189 · 2023: $1,502 · 2024: $1,275 · 2025: $1,211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,987.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $626.76 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $557.51 | 2021-2025 | Enhertu, Calquence, Lynparza |
| Merck Sharp & Dohme LLC | $481.27 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Daiichi Sankyo INC. | $432.60 | 2022-2025 | Enhertu, Injectafer, Datroway |
| Lilly USA, LLC | $308.49 | 2022-2025 | Jaypirca, Verzenio, Retevmo |
| Seagen INC. | $271.46 | 2022-2023 | Padcev, Adcetris, Tukysa |
| Incyte Corporation | $254.44 | 2021-2025 | Jakafi, Monjuvi, Zynyz |
| Genmab U.S., INC. | $231.18 | 2022-2025 | Tivdak, Epkinly |
| Bayer Healthcare Pharmaceuticals INC. | $207.83 | 2019-2025 | |
| Janssen Biotech, INC. | $195.10 | 2022-2025 | Darzalex, Tecvayli, Talvey |
| Novocure INC. | $155.94 | 2019-2025 | Optune Gio, Optune |
| Astellas Pharma US INC | $146.62 | 2023-2025 | Padcev, Xtandi, Xospata |
| Novartis Pharmaceuticals Corporation | $137.43 | 2022-2025 | |
| Stemline Therapeutics INC. | $120.76 | 2023-2025 | Orserdu |
| Amgen INC. | $106.95 | 2022-2023 | Lumakras, Xgeva, Nplate |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.